항상 최고의 진료를
약속합니다

윤보성 교수
  • 전문분야
    부인암, 부인종양(자궁근종, 선근증, 난소종양, 자궁내막증), 단일공수술, 로봇수술, 복강경수술, 자궁경수술, 비정상자궁경부세포
오전 화, 수, 금, 토(1,3,5주)
오후 화, 수
교수경력
  • 연세대학교
  • 차의과학대학교
진료경력
  • 연세대학교 신촌세브란스병원 산부인과
  • 차의과학대학교 강남차병원 산부인과
  • 차의과학대학교 일산차병원 산부인과
  • 차의과학대학교 일산차병원 부인종양센터
학회·연구·연수·수상 경력
  • 미국 Yale University 부인종양학 연수
  • 대한부인종양학회 수련위원회 위원
  • Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate. Eur J Obstet Gynecol Reprod Biol. 2018 May;224:133-136.
  • Therapeutic outcomes of methotrexate injection in unruptured interstitial pregnancy. Obstet Gynecol Sci. 2017 Nov;60(6):571-578.
  • Effect of menstrual phase on the surgical treatment of ovarian cysts. J Obstet Gynaecol. 2017 Oct;37(7):919-923.
  • Minimally invasive compared with open surgery in patients with borderline ovarian tumors. Gynecol Oncol. 2017 Jun;145(3):508-512.
  • Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer. Int J Gynecol Cancer. 2017 May;27(4):738-742.
  • Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist. Obstet Gynecol Sci. 2017 Jan;60(1):69-73.
  • Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system. J Gynecol Oncol. 2016 Aug 2:e1.
  • Redefining the origin and evolution of ovarian cancer: a hormonal connection. Endocr Relat Cancer. 2016 Sep;23(9):R411-22.
  • The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence. Int J Gynaecol Obstet. 2016 Sep;134(3):256-9.
  • Impact of opportunistic salpingectomy on anti-Müllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial. BJOG. 2017 Jan;124(2):314-320.
  • The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis. Eur J Cancer Prev. 2017 Jan;26(1):78-85.
  • Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial. Hum Reprod. 2016 Feb;31(2):332-8.
  • Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:177-81.
  • Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis. Taiwan J Obstet Gynecol. 2015 Aug;54(4):412-5.
  • Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist. Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:62-7.
  • A Randomized Comparison of Laparoendoscopic Single-Site Hysterectomies: Total Laparoscopic Hysterectomy Versus Laparoscopically Assisted Vaginal Hysterectomy. J Laparoendosc Adv Surg Tech A. 2015 Jul;25(7):541-7.
  • Operative outcomes of single-port-access laparoscopy-assisted vaginal hysterectomy compared with single-port-access total laparoscopic hysterectomy. Taiwan J Obstet Gynecol. 2014 Dec;53(4):486-9.
  • Laparoscopic salpingotomy using the floseal hemostatic sealant in patients with tubal pregnancy. J Laparoendosc Adv Surg Tech A. 2014 Sep;24(9):651-5.
  • Effectiveness of different routes of misoprostol administration before operative hysteroscopy: a randomized, controlled trial. Fertil Steril. 2014 Aug;102(2):519-24.
  • Is myomectomy in women aged 45 years and older an effective option? Eur J Obstet Gynecol Reprod Biol. 2014 Jun;177:57-60.
  • Impact on ovarian reserve after laparoscopic ovarian cystectomy with reduced port number: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2014 May;176:34-8.
  • Risk factors for treatment failure of CO2 laser vaporization in cervical intraepithelial neoplasia 2. Arch Gynecol Obstet. 2014 Jul;290(1):115-9.
  • Laparoendoscopic single-site versus conventional laparoscopic gynecologic surgery: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2013 Oct;209(4):317.e1-9.
  • Would fewer port numbers in laparoscopy produce better cosmesis? Prospective study. J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):68-73.
  • Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer. Gynecol Oncol. 2013 Sep;130(3):470-3.
  • Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol. 2013 Oct;209(4):358.e1-4.
  • Comparison of single-port, two-port and four-port laparoscopic surgery for cyst enucleation in benign ovarian cysts. Gynecol Obstet Invest. 2013;76(1):57-63.
  • Single-port access total laparoscopic hysterectomy for large uterus. Gynecol Obstet Invest. 2013;75(1):16-20.
  • Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer. J Gynecol Oncol. 2012 Apr;23(2):91-7.
  • Single-port versus conventional laparoscopic salpingectomy in tubal pregnancy: a comparison of surgical outcomes. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):190-3.
  • Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium. Arch Gynecol Obstet. 2012 Feb;285(2):473-8.
  • Can misoprostol reduce blood loss in laparoscopy-assisted vaginal hysterectomy? Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):248-51.
  • Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study. Int J Gynecol Cancer. 2011 May;21(4):673-7.
  • Rapid recurrence of uterine smooth muscle tumor of uncertain malignant potential as leiomyosarcoma. Int J Gynaecol Obstet. 2011 Jun;113(3):244-5.
  • Spontaneous vaginal expulsion of uterine myoma after magnetic resonance-guided focused ultrasound surgery. J Minim Invasive Gynecol. 2011 Jan-Feb;18(1):131-4.
  • Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction. Fertil Steril. 2011 Mar 1;95(3):1152-5.
  • The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women. J Gynecol Oncol. 2010 Jun;21(2):102-5.
  • Cellular fibroma of the ovary containing Leydig cell hyperplasia: a case report. J Gynecol Oncol. 2010 Mar;21(1):56-8.
  • Single-port laparoscopic salpingectomy for the surgical treatment of ectopic pregnancy. J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):26-9.
  • Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors. Yonsei Med J. 2008 Apr 30;49(2):272-8.
  • NM23 as a prognostic biomarker in ovarian serous carcinoma. Mod Pathol. 2008 Jul;21(7):885-92.
  • Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):110-5.
  • Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynaecol Obstet. 2007 Jul;98(1):48-53.
  • An ovarian steroid cell tumor causing virilization and massive ascites. Yonsei Med J. 2007 Feb 28;48(1):142-6.
  • Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol. 2007 Apr;105(1):199-204.
  • Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer. 2007 Jan;46(1):1-9.
  • Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas. Int J Gynaecol Obstet. 2006 Dec;95(3):272-7.
  • Expression profiling of cyclin B1 and D1 in cervical carcinoma. Exp Oncol. 2006 Mar;28(1):44-8.
  • Expression of c-erbB-2 oncoprotein and the prognosis of patients with cervical carcinoma. Int J Gynaecol Obstet. 2006 Feb;92(2):151-2.
  • Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma. Gynecol Oncol. 2005 Dec;99(3):585-90.
  • Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix. Int J Gynaecol Obstet. 2005 Oct;91(1):47-52
  • Clinical usefulness of cervicogram as a primary screening test for cervical neoplasia. Yonsei Med J. 2005 Apr 30;46(2):213-20.
  • Survey of the characteristics and satisfaction degree of the patients using a pessary. Int Urogynecol J Pelvic Floor Dysfunct. 2005 May-Jun;16(3):182-6; discussion 186.